Form 4 for DGX Quest Diagnostics
Accepted 2023-02-27 00:00:00 ET · period of report 2023-02-23 · accession 0001022079-23-000032 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-27 | 2023-02-23 | DGX | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | F - Tax | $147.86 | -195 | 7,810 | -2% | -$28.8K |
| D | 2023-02-27 | 2023-02-23 | DGX | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | A - Grant | $0.00 | +2,094 | 9,904 | +27% | $0 |
| D | 2023-02-27 | 2023-02-23 | DGX | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | A - Grant | $0.00 | +8,270 | 8,270 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-23 | F | D | 195 | $147.86 | 7,810 | D | — | — | (F1) Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted share units. |
| 2 | Common | Common Stock | 2023-02-23 | A | A | 2,094 | $0.00 | 9,904 | D | — | — | (F2) Represents an award of restricted share units. |
| 3 | Derivative | Non-Qualifed Stock Option (right to buy) | 2023-02-23 | A | A | 8,270 | $0.00 | 8,270 | D | $143.33 · — to 2033-02-23 | 8,270 Common Stock | (F4) The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. |